Ligand Pharmaceuticals LGND Operating Income
Operating Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's operating income?
- Ligand Pharmaceuticals (LGND) reported operating income of $17.37M in Q1 2026.
- How has Ligand Pharmaceuticals's operating income changed year-over-year?
- Ligand Pharmaceuticals's operating income increased by 148.0% year-over-year, from -$36.22M to $17.37M.
- What is the long-term trend for Ligand Pharmaceuticals's operating income?
- Over 2 years (2021 to 2025), Ligand Pharmaceuticals's operating income has grown at a -37.2% compound annual growth rate (CAGR), from $103.85M to $41M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.